Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3. — المؤلف: Aguado, J M — Antimicrobial agents and chemotherapy 19960102

المؤلف
Aguado, J M
النشر
Antimicrobial agents and chemotherapy 19960102
الوصف
1643-5 p.
الموضوعات
Adult؛ Antibodies, Viral؛ Cytomegalovirus؛ Cytomegalovirus Infections؛ Female؛ Ganciclovir؛ Heart Transplantation؛ Humans